VYRO

Vyro is a biotechnology company focused on developing cancer-killing, or "oncolytic", viruses (OVs) designed to target adult and pediatric central nervous system (CNS) tumors.

 

 

Founded by scientists from The Human Genome and Stem Cell Research Center (HUG-CELL) of the Institute of Biosciences of the University of São Paulo, based on pioneering research on the oncolytic properties of the Zika Virus (ZIKV).

CNS ADULT TUMORS: A HUGE UNMET MEDICAL NEED

How common is this cancer?

Captura de Tela 2021-05-13 às 16.59.30.

CNS PEDIATRIC TUMORS

Brain cancer has surpassed leukemia as the deadliest form of childhood cancer, which is the No. 1 disease-related killer of children under 15.

 

Despite this, there has never been a drug developed and approved specifically for malignant pediatric brain tumors.

Captura de Tela 2021-05-13 às 17.08.08.

National Cancer Institute

Design sem nome (2).png